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Image Questionnaire (BIQ) scales, respectively, recorded at 
skin clips removal and either at 6 months after surgery.
Results Overall, 32 patients were enrolled and com-
pleted the 6 month of follow-up. At clips removal, lapa-
roscopic approaches offered better scar result than open 
surgery according to the POSAS. However, at 6 months, 
no differences were detected between VLP and open, 
whereas ML was still associated with a better scar out-
come (p = 0.001). This finding was also confirmed by 
both BIQ scales, including the body image score (ML 
9.8 ± 1.69, open 15.73 ± 3.47, VLP 13.27 ± 3.64; 
p = 0.001) and the cosmetic score (ML 16.6 ± 4.12, open 
10 ± 1.9, LP 12.91 ± 3.59; p = 0.001). Small sample size 
and lack of randomization represent the main limitations 
of this study.
Conclusions ML RP offers a better cosmetic outcome 
when compared to both open and standard laparoscopic 
RP, representing a step toward minimal surgical scar. The 
impact of scar outcome on RP patients’ quality of life 
remains to be determined.
Keywords Mini-laparoscopy · Radical prostatectomy · 
POSAS · Surgical scar
Introduction
Radical prostatectomy (RP) represents the standard surgi-
cal treatment for patients with low- and intermediate-risk 
localized PCa and a life expectancy >10 years [1]. Open 
RP has represented the gold standard technique for over 
30 years, and it is still routinely performed [2]. The laparo-
scopic [3] and, more recently, the robot-assisted approach 
[4] have been largely adopted with the aim of reducing sur-
gical morbidity.
Abstract 
Purpose To compare patient scar satisfaction after retro-
pubic, standard laparoscopic, mini-laparoscopic (ML) and 
open radical prostatectomy (RP).
Methods Patients undergoing RP for a diagnosis of local-
ized prostate cancer at a single academic hospital between 
September 2012 and December 2013 were enrolled in 
this prospective nonrandomized study. The patients were 
included in three study arms: open surgery, VLP and ML. 
A skin stapler was used for surgical wound closure in all 
cases. Demographic and main surgical outcomes, including 
perioperative complications, were analyzed. Surgical scar 
satisfaction was measured using the Patient and Observer 
Scar Assessment Questionnaire (POSAS) and the two Body 
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Over the last 5 years, the field of urologic surgery has 
witnessed an increasing interest toward scarless tech-
niques, with the ultimate aim of further lowering surgical 
morbidity and expediting postoperative recovery. Based on 
this concept, novel surgical approaches such as natural ori-
fice translumenal endoscopic surgery (NOTES) and laparo-
endoscopic single-site surgery (LESS) have been explored 
[5]. However, these techniques carry some limitations, 
including an unfavorable ergonomy and the lack of optimal 
instrumentation, are still under development.
On the other hand, mini-laparoscopy (ML), which was 
initially conceived in the early 90 s maintaining the key 
principles of standard laparoscopy (i.e., triangulation), has 
been rediscovered thanks to the recent availability of more 
reliable instrumentation [6]. In terms of surgical scarring, 
the use of trocars of smaller diameter, not requiring formal 
skin closure, could potentially translate into less pain. A 
broad range of common urological procedures have safely 
and effectively performed with this newly re-discovered 
technique, mostly for kidney diseases [7]. Porpiglia et al. 
recently showed a better patients scar satisfaction using ML 
instruments to carry out laparoscopic pyeloplasty [8].
Despite the large number of studies comparing oncolog-
ical and functional outcomes between the different surgi-
cal approaches [9, 10], available literature on objective scar 
assessment of patients undergoing RP remains anecdotal 
[11].
The aim of present study was to analyze the cosmetic 
result of ML RP compared with open and standard laparo-
scopic approaches.
Patients and methods
Study design
This is a prospective nonrandomized study carried out in 
a tertiary care institution (Braga Hospital, Braga, Portugal) 
between September 2012 and December 2013. The study 
was conducted in accordance with good clinical practice 
guidelines and the Declaration of Helsinki, and the local 
institutional review board approved the protocol. All sub-
jects gave written informed consent before enrollment in 
the study. Patients were allocated in 3 study groups accord-
ing to surgeon preference: open surgery, standard laparos-
copy and ML.
Patients
Eligible patients had a diagnosis of localized prostate can-
cer with a PSA level ≤10 ng/ml, biopsy Gleason score ≤7, 
age ≤70 years, trans-rectal ultrasound prostate volume esti-
mated ≤50 cc, life expectative ≥10 years and American 
Society of Anesthesiology score (ASA score) ≤2. Exclu-
sion criteria were previous pelvic surgery or trans-urethral 
resection of the prostate (TURP), diabetes mellitus, chronic 
use of corticosteroid medication.
Surgical techniques
All procedures were performed by a senior surgeon with 
extensive laparoscopic experience (E.L.). For the open 
approach, a standard retropubic technique through an infra-
umbilical midline incision was used [12]. For both lapa-
roscopic and ML approaches, the same surgical technique 
was adopted [13]. A limited pelvic lymphadenectomy 
was selectively performed in high-risk (Gleason score >6) 
patients. In brief, the patient was placed in Trendelenburg 
supine position (Fig. 1). A 10-mm skin incision was made 
laterally to umbilical scar in order to create a preperitoneal 
space by introducing a dissecting balloon trocar. After that, 
the balloon trocar was replaced by a 12-mm optical tro-
car. Two 3.5-mm trocars (5 mm in case of standard lapa-
roscopy) were positioned medially to the anterior supe-
rior iliac spine, bilaterally. One 5-mm trocar was placed 
approximately 3 fingerbreadths medially to the left anterior 
superior iliac spine while another 3.5-mm (5 mm in case 
of standard laparoscopy) trocar in the right para-rectal line, 
between the optical trocar and the previously placed right 
3.5-mm trocar. In all procedures, sterile skin closure clips 
were used and removed at postoperative day 7 (Fig. 2). Pro-
tocol for pain management was the same for all patients 
regardless the technique. Patients received intravenous 
ketorolac for 48 h. In addition, tramadol was given “on 
demand” for severe pain.
Outcomes
Baseline demographic, surgical outcomes, intra (graded 
according to Satava) [14]- and postoperative complications 
(graded according to Clavien–Dindo) [14]), and pathol-
ogy findings were recorded. Biochemical recurrence was 
defined according to current guidelines as single PSA 
>0.2 ng/ml followed by a subsequent rise. Functional out-
comes related to continence (number of pads per day) and 
erectile function (IIEF score) were recorded. Scar evalua-
tion and patient scar satisfaction represented the primary 
outcomes. The first one was performed at time of clips 
removal and at 6 month after surgery. At both times, a 
validated assessment tool, the Patient and Observer Scar 
Assessment Questionnaire (POSAS), was used [15, 16]). 
This consists of two scales with six items rating 1–10 
where the highest score reflects the worst finding. The 
observer items were collected by an “observer” (a physi-
cian part of the research team). Patient scar satisfaction was 
assessed using the Body Image Questionnaire (BIQ) [17] at 
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Fig. 1  Patient position (a) and trocar placement for standard laparoscopy (b) and mini-laparoscopic (c) radical prostatectomy
Fig. 2  Surgical wound and scar at 6 months after open or laparoscopic approaches
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6 months after surgery. This is composed of two spheres: 
five questions about operation impact on body image (over-
all range 5-low to 20-high impact) and three questions 
about satisfaction on scar appearance (overall range 3-very 
unsatisfied to 24-very satisfied). A common postopera-
tive protocol in terms of analgesia was employed. A visual 
analog pain score (VAPS) at postoperative day 1 and at 
time of discharge was used to measure surgical pain.
Statistical analysis
The statistical significance of differences in means and pro-
portions was tested with one-way ANOVA test followed by 
Bonferroni post hoc test and the Pearson χ2 test, respec-
tively. Statistical significance was set at p < 0.05. All data 
were analyzed using Statistical Package for Social Sciences 
(SPSS) 17.0 for Windows.
Results
Overall, 32 patients were enrolled and completed the 
6-month follow-up. Eleven patients underwent to open RP, 
ten to standard laparoscopic RP, and eleven to ML RP. No 
significant differences were detected between the groups in 
terms of baseline demographics (Table 1).
Surgical outcomes, pathology findings and functional 
outcomes are summarized in Table 2. Only one (9 %) Sat-
ava grade 1 intraoperative complication occurred during a 
ML RP. Postoperative complications were mostly Clavien 
grade 1. On pathology, the disease was mostly organ-con-
fined low-grade cancer and negative surgical margins. No 
patient developed biochemical recurrence at 6 months after 
surgery. There was no difference in terms of 6-month func-
tional outcomes between groups.
Table 3 summarizes analgesic use, pain assessment, scar 
evaluation and patient scar satisfaction. Both laparoscopic 
approaches reported a lower VAPS than open surgery at 
postoperative day 1 (p = 0.01) and at patients discharge 
(p = 0.006). Moreover, a lower (nonstatistically significant) 
use of in-hospital “on-demand” tramadol was recorded for 
minimally invasive techniques compared to open (p = 0.1). 
Scar assessment was deemed to be better at clips removal 
for laparoscopic approaches compared to open, by the 
observer (p = 0.001) and the patient (p = 0.001). At 
6 months, according to the observer assessment, standard 
laparoscopy and mini-laparoscopy were still both better 
than open (p = 0.001), whereas ML performed better than 
standard lap and open according to the patient (p = 0.001).
This finding was also confirmed by BIQ assessment at 
6 months when patients in the ML group scored higher 
than those of open and standard laparoscopy group for 
both body image score (p = 0.001) and cosmetic score 
(p = 0.001).
Discussion
Assessment of surgical scars represents a challenging task 
as both patient-related factors, such as age and concomitant 
disease, and tissue-related features (blood supply, infec-
tion) affect healing of surgical wounds. Thus, investigators 
are still making several attempts to devise a reliable and 
valid scar assessment scale in a broad range of scar types 
[15].
The use of smaller laparoscopic instruments (i.e., mini-
laparoscopy) has been recently rediscovered with the pur-
pose to minimize patient morbidity and obtain a scarless 
surgery preserving the principles of standard laparoscopy, 
above all instrument triangulation. A variety of urological 
procedures have been successfully performed using ML, 
including pyeloplasty, radical nephrectomy, radical prosta-
tectomy and adrenalectomy [7].
For most patients contemplating urological surgery, cos-
mesis is of less concern than surgeon reputation and avoid-
ance of surgical complications [18]. The aim of the present 
study was to compare three currently available surgical 
Table 1  Demographics
Values expressed as mean ± (SD) or n (%)
ns = nonsignificant (p > 0.05) for all pairwise comparisons
VLP video laparoscopy, ML mini-laparoscopy, BMI body mass index, 
PSA prostate specific antigen, ED erectile dysfunction
^
 Based on IIEF (International Index Erectile Function): 22–25: no 
erectile dysfunction; 17–21: mild erectile dysfunction; 12–16: mild-
to-moderate erectile dysfunction; 8–11: moderate erectile dysfunc-
tion; 5–7: severe erectile dysfunction
Open  
(n = 11)
VLP  
(n = 10)
ML  
(n = 11)
p value
Age, years 63.2 ± 3.4 67.1 ± 2.9 64.4 ± 4.8 ns
BMI, kg/m2 25.1 ± 2.1 23.6 ± 1.2 24.7 ± 0.9 ns
ASA score
 1 8 (72.7) 8 (80) 9 (81.8) ns
 2 3 (27.3) 2 (20) 2 (18.2)
Prostate vol-
ume, cc
37.1 ± 8.3 38.3 ± 5.4 44.5 ± 2.3 ns
PSA, ng/dl 6.05 ± 2.7 5.89 ± 1.6 5.65 ± 1.7 ns
Biopsy Gleason score
 Score 6 7 (63.6) 9 (90) 9 (81.8) ns
 Score 7 4 (36.4) 1 (10) 2 (18.2)
Baseline erectile function^
 IEEF score 21.1 (2.7) 21.2 (2.9) 20.9 (2.8) ns
 No/mild ED 11 (100) 10 (100) 11 (100)
 Moderate/
severe ED
0 (0) 0 (0) 0 (0)
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Table 2  Surgical outcomes, 
pathology findings and 
functional outcomes
Values expressed as 
mean ± (SD) or n (%)
ns = nonsignificant (p > 0.05) 
for all pairwise comparison
Intraoperative complications: 
Satava grade 1 = substitution 
of a 3 mm with a 5-mm trocar; 
Satava grade 2 = conversion 
to open. Postoperative 
complications: Clavien Grade 
1 = fever
VLP video laparoscopy, ML 
mini-laparoscopy, ED erectile 
dysfunction, GS Gleason score
^
 Based on IIEF (International 
Index Erectile Function): 
22–25: no erectile dysfunction; 
17–21: mild erectile 
dysfunction; 12–16: mild-to-
moderate erectile dysfunction; 
8–11: moderate erectile 
dysfunction; 5–7: severe erectile 
dysfunction
Open (n = 11) VLP (n = 10) ML (n = 11) p value
Surgical outcomes
Operative time, min 110.30 ± 18.50 124.60 ± 15.70 118.69 ± 25.20 ns
Hospital stay, days 4.02 ± 1.50 3.89 ± 1.23 3.79 ± 1.51 ns
Intraop. complications
 Satava grade 1 0 0 1 (9) ns
 Satava grade 2 0 0 0
Postop. complications
 Clavien grade 1 2 (18.1) 1 (10) 1 (9) ns
 Clavien grade 2 0 0 0
Time to catheter removal, days 10 ± 2.51 10 ± 1.31 10 ± 1.50 ns
Pathology findings
pStage
 T2b 1 (9) 2 (20) 1 (9) ns
 T2c 9 (82) 8 (80) 9 (82)
 T3a 1 (9) 0 1 (9)
Gleason score
 6 7 (63.3) 7 (70) 8 (72.7) ns
 7 4 (36.4) 3 (30) 3 (27.3)
Positive surgical margins 3 (27.2) 2 (20) 2 (18.2) ns
12-month functional outcomes
Continence
 0–1 pad 8 (91) 9 (90) 11 (100) ns
 >2 pads 1 (9) 1 (10) 0 (0)
Erectile function^
 IIEF score 12.9 (3.1) 14.5 (2.6) 14.2 (3.1) ns
 No/mild ED 7 (64) 9 (90) 9 (82)
 Moderate/severe ED 4 (36) 1 (10) 2 (18)
Table 3  Analgesic use, pain assessment and cosmetic outcomes in the three study groups
Values expressed as mean ± SD
ns = nonsignificant (p > 0.05) for all pairwise comparisons
VAPS visual analog pain score, POSAS Patient and Observer Scar Assessment Questionnaire, BIQ Body Image Questionnaire, ML mini-laparos-
copy, VLP video laparoscopy
* p significant for pairwise comparison between ML-Open and standard VLP-Open (nonsignificant for other comparisons)
^
 p significant for pairwise comparison between ML-Open and ML-VLP (nonsignificant for other comparisons)
Open (n = 11) Standard VLP (n = 10) ML (n = 11) p value
Use of “on-demand” tramadol, mg 40 ± (51) 9 ± (30) 9 ± (30) ns
VAPS
 Postop. day 1 2.82 ± 0.75 2.02 ± 0.89* 1.72 ± 0.82* 0.01*
 Discharge 2.09 ± 0.7 1.18 ± 0.87* 0.90 ± 0.88* 0.006*
POSAS at clips removal
 Observer 18.36 ± 3.44 10.64 ± 4.03 8.4 ± 2.22 0.001*
 Patient 23.64 ± 6.19 15.91 ± 4.85 10.5 ± 3.24 0.001*
POSAS at 6 months
 Observer 14.73 ± 3.50 9.09 ± 3.48 7.5 ± 8.10 0.001*
 Patient 18.01 ± 4.92 14.64 ± 3.17 8.10 ± 2.23 0.001^
BIQ at 6 months
 Body image score 15.73 ± 3.47 13.27 ± 3.64 9.8 ± 1.69 0.001^
 Cosmetic score 10 ± 1.9 12.91 ± 3.59 16.6 ± 4.12 0.001^
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approaches for RP in terms of surgical scars and their per-
ception by the patients. With the recent interest in scarless 
techniques in urology, this comparative assessment can be 
regarded as an attempt to better understand how patients 
undergoing this procedure perceive the impact of surgical 
scars on their body image. Bucher reported as patients are 
usually fascinated by new surgical approaches in particular 
when surgical risk is similar to traditional approach and a 
scar-free surgery may be achieved [19].
Interestingly, our findings suggest that at time of suture 
removal (7 days after surgery in the present study), both 
patient and physician have a better perception of scar 
related to laparoscopic approaches compared to those 
related to open surgery. However, at 6 months after surgery, 
this finding is only confirmed by physician while from a 
patient’ point of view standard laparoscopy and open 
approach perform similarly, with only mini-laparoscopy 
holding a better scar assessment. These findings might be 
explained by fact that scarring is a time-dependent process 
[20] and cosmetic satisfaction may be fluid [21].
Delongchamps et al. [11] also found no significant differ-
ence neither in patient’s scar satisfaction nor in scar-related 
impact on quality of life between open and standard laparo-
scopic RP at 3 months postoperatively. In particular, using a 
nonvalidated questionnaire to compute the impact of scar on 
quality of life (where “0” as no impact and “10” as the high-
est impact), the median reported values were 0 and 1, respec-
tively, for patients underwent to open and laparoscopic RP.
In a recent review on public perception of scarless sur-
gery, Autorino et al. [5] showed that safety and efficacy 
are as the primary surgical outcomes for patients while 
scar issue is such significant just when equivalence results 
and risks are assured. In a prospective comparative study, 
Porpiglia et al. showed that patients who underwent mini-
laparoscopic pyeloplasty were significantly more satisfied 
with their cosmetic result than those who had standard 
laparoscopic approach [8]. To note, this finding was also 
obtained using the POSAS Questionnaire. A better cos-
metic outcome using smaller trocar has also been reported 
in general surgery literature thought comparative studies on 
standard laparoscopic cholecystectomy [22, 23]. Matching 
these findings with ours and those ones of Delongchamps 
[11], one can speculate that cosmetic result is a secondary 
concern for patient undergone to oncological surgery and it 
should be considered as primary just when oncological and 
functional outcomes are comparable.
A common postoperative analgesia protocol was used 
for all study groups. A lower use of “on-demand” anal-
gesics was recorded for VLP and ML compared to open, 
without reaching a statistical significance. There were no 
differences in terms of VAPS between the two laparoscopic 
approaches. A recent systematic review looking at this 
same parameter in patients undergoing cholecystectomy 
concluded that ML seems to provide a lower degree of 
pain when compared to standard laparoscopy [24]. This 
may be explained by the fact that our ML–RP was not a 
“pure” 3-mm surgery. This is due to the drawbacks of cur-
rently available 3 mm instrumentation, such as the absence 
of 3 mm Hem-o-lok applicator and the low resolution of 
3 mm telescope.
Some study limitations should be recognized. The sam-
ple size in each of the study arms is limited. As this was 
conceived as an exploratory study, a formal sample size 
calculation was not performed. However, the prospective 
study design, despite the lack of randomization, represents 
a notable study feature. The short length of follow-up and 
the lack of quality of life assessment can also be regarded 
as major limitations. More robust analysis has been already 
performed by others about surgical, functional and onco-
logical outcomes for different radical prostatectomy 
approaches [9, 10, 25]. The lack of a quality of life assess-
ment does not allow determining how the cosmetic result 
impact this in oncological patients.
Despite these limitations, to the best of our best knowl-
edge, this represents the first prospective study assessing 
these three approaches for RP using validated assessment 
tools (i.e., POSAS, BIQ, VAPS) and our results indicate 
that ML approach might offer a better surgical scar from 
the patient’s point of view. Thus, further studies are war-
ranted in this field.
Conclusions
ML can be regarded as an emerging minimally invasive 
surgical option in patients undergoing RP. Findings from 
the present prospective study suggest that ML can offer a 
better cosmetic outcome when compared to both open and 
standard laparoscopy, representing a significant step toward 
minimal surgical scar and less surgical pain. How these fac-
tors impact the overall quality of life of this patient popula-
tion remains to be addressed.
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